Back to Journals » Journal of Blood Medicine » Volume 1

Cinryze™ as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety

Total article views   HTML views PDF downloads Totals
19,997 Dovepress* 15,863+ 2,804 18,667
PubMed Central* 4,134 564 4,698
Totals 19,997 3,368 23,365
*Since 24 August 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 0 14

View citations on PubMed Central and Google Scholar